The goal of this program is to provide important clinical data on issues related to the management of HCV.
This activity has been designed to meet the educational needs of hepatologists, gastroenterologists, physician assistants, and nurse practitioners involved in the care of patients with HCV.
After completing this activity, the participants should be better able to:
Describe the detrimental effects of chronic hepatitis C virus (HCV) to emphasize the need for diagnosis, treatment, and long-term patient management
Demonstrate strategies for incorporating treatment updates into clinical practice to optimize initial treatment and ongoing care for patients with HCV
Analyze recently approved and emerging treatment options in order to recognize how new agents improve the standard of care for all patients chronically infected with HCV
Identify the patient characteristics that are important to consider when selecting the most appropriate treatment regimen for maximizing HCV patient outcomes
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and the Chronic Liver Disease Foundation (CLDF). The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.
The University of Cincinnati designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.
Learner Assurance Statement
The University of Cincinnati is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members’ significant relationships with drug or device manufacturer(s). The University of Cincinnati is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.
Americans with Disabilities Act
The event staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.). Please contact us prior to the event at 888-582-4532.
Joint providership by the University of Cincinnati and the Chronic Liver Disease Foundation.
Supported by an independent educational grant from AbbVie.